Wordt geladen...

Paget's disease of bone treated with a five day course of oral tiludronate.

Chloro-4-phenyl thiomethylene bisphosphonate (tiludronate) is a new drug which can be used as an inhibitor of bone resorption. As it remains in bone for a long time, and as mineralisation defects have only been seen at doses much higher than those required to decrease osteoclastic activity, it could...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ann Rheum Dis
Hoofdauteurs: Reginster, J Y, Lecart, M P, Deroisy, R, Ethgen, D, Zegels, B, Franchimont, P
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 1993
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004956/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8427515/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.1.54
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!